Abingdon Health PLC Announces AGM Date and Publishes 2025 Annual Report

Abingdon Health PLC ( (GB:ABDX) ) just unveiled an announcement.

Abingdon Health PLC has announced the date for its Annual General Meeting, which will take place on December 10, 2025, at its York Biotech Campus offices. The company has also published its 2025 Annual Report, which is available to shareholders and on its website. This announcement is part of Abingdon Health’s ongoing efforts to maintain transparency and engage with its stakeholders, reinforcing its position as a key player in the med-tech industry.

The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.

Spark’s Take on GB:ABDX Stock

According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.

Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.

To see Spark’s full report on GB:ABDX stock, click here.

More about Abingdon Health PLC

Abingdon Health PLC is a leading med-tech contract service provider specializing in lateral flow product development, regulatory support, technology transfer, and manufacturing services. The company serves an international customer base, focusing on areas such as infectious disease, clinical testing, animal health, and environmental testing. It offers comprehensive regulatory services to the in vitro diagnostic and medical device industries, with operations in York and Doncaster, England, and Madison, Wisconsin, USA.

Average Trading Volume: 165,756

Technical Sentiment Signal: Hold

Current Market Cap: £18.2M

See more insights into ABDX stock on TipRanks’ Stock Analysis page.